{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T20:38:26Z","timestamp":1784061506064,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T00:00:00Z","timestamp":1528675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T00:00:00Z","timestamp":1528675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the National Key Research and Development Program of China: The registry study of rare diseases in children","award":["No.2016YFC0901505"],"award-info":[{"award-number":["No.2016YFC0901505"]}]},{"name":"Beijing Key Laboratory of Molecular Diagnosis and Study on Pediatric Genetic Diseases","award":["No. Z141107004414036"],"award-info":[{"award-number":["No. Z141107004414036"]}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["P30DK081943"],"award-info":[{"award-number":["P30DK081943"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00467-018-3988-1","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T00:05:40Z","timestamp":1528675540000},"page":"1731-1739","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Urinary epidermal growth factor as a prognostic marker for the progression of Alport syndrome in children"],"prefix":"10.1007","volume":"33","author":[{"given":"Baihong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viji","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangrui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kretzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,11]]},"reference":[{"key":"3988_CR1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nrneph.2012.259","volume":"9","author":"J JKruegel","year":"2013","unstructured":"JKruegel J, Rubel D, Gross O (2013) Alport syndrome-insights from basic and clinical research. Nat Rev Nephrol 9:170\u2013178","journal-title":"Nat Rev Nephrol"},{"key":"3988_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1365-2265.1989.tb01239.x","volume":"31","author":"S Dagogo-Jack","year":"1989","unstructured":"Dagogo-Jack S, Marshall SM, Kendall-Taylor P, Alberti KG (1989) Urinary excretion of human epidermal growth factor in the various stages of diabetic nephropathy. Clin Endocrinol 31:167\u2013173","journal-title":"Clin Endocrinol"},{"key":"3988_CR3","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nrneph.2014.184","volume":"10","author":"HM Kok","year":"2014","unstructured":"Kok HM, Falke LL, Goldschmeding R, Nguyen TQ (2014) Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease. Nat Rev Nephrol 10:700\u2013711","journal-title":"Nat Rev Nephrol"},{"key":"3988_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0167-0115(88)90424-7","volume":"23","author":"AL Mattila","year":"1988","unstructured":"Mattila AL, Viinikka L, Saario I, Perheentupa J (1988) Human epidermal growth factor: renal production and absence from plasma. Regul Pept 23:89\u201393","journal-title":"Regul Pept"},{"key":"3988_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1677\/joe.0.1390227","volume":"139","author":"PE Jorgensen","year":"1993","unstructured":"Jorgensen PE, Hilchey SD, Nexo E, Poulsen SS, Quilley CP (1993) Urinary epidermal growth factor is excreted from the rat isolated perfused kidney in the absence of plasma. J Endocrinol 139:227\u2013234","journal-title":"J Endocrinol"},{"issue":"2","key":"3988_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1464-5491.1989.tb02098.x","volume":"6","author":"ER Mathiesen","year":"1989","unstructured":"Mathiesen ER, Nexo E, Hommel E, Parving HH (1989) Reduced urinary excretion of epidermal growth factor in incipient and overt diabetic nephropathy. Diabet Med 6(2):121\u2013126","journal-title":"Diabet Med"},{"key":"3988_CR7","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/ki.1989.266","volume":"36","author":"R Safirstein","year":"1989","unstructured":"Safirstein R, Zelent AZ, Price PM (1989) Reduced renal prepro-epidermal growth factor mRNA and decreased EGF excretion in ARF. Kidney Int 36:810\u2013815","journal-title":"Kidney Int"},{"key":"3988_CR8","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1038\/ki.1996.521","volume":"50","author":"E Ranieri","year":"1996","unstructured":"Ranieri E, Gesualdo L, Petrarulo F, Schena FP (1996) Urinary IL-6\/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy. Kidney Int 50:1990\u20132001","journal-title":"Kidney Int"},{"key":"3988_CR9","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1159\/000013485","volume":"19","author":"YK Tsau","year":"1999","unstructured":"Tsau YK, Chen CH (1999) Urinary epidermal growth factor excretion in children with chronic renal failure. Am J Nephrol 19:400\u2013404","journal-title":"Am J Nephrol"},{"key":"3988_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1046\/j.1523-1755.2000.00153.x","volume":"58","author":"G Grandaliano","year":"2000","unstructured":"Grandaliano G, Gesualdo L, Bartoli F, Ranieri E, Monno R, Leggio A, Paradies G, Caldarulo E, Infante B, Schena FP (2000) MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy. Kidney Int 58:182\u2013192","journal-title":"Kidney Int"},{"key":"3988_CR11","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1440-1797.2008.01051.x","volume":"14","author":"M Stangou","year":"2009","unstructured":"Stangou M, Alexopoulos E, Papagianni A, Pantzaki A, Bantis C, Dovas S, Economidou D, Leontsini M, Memmos D (2009) Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy. Nephrology 14:613\u2013620","journal-title":"Nephrology"},{"key":"3988_CR12","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.etp.2012.06.005","volume":"65","author":"Y Togashi","year":"2013","unstructured":"Togashi Y, Miyamoto Y (2013) Urinary cystatin C as a biomarker for diabetic nephropathy and its immunohistochemical localization in kidney in Zucker diabetic fatty (ZDF) rats. Exp Toxicol Pathol 65:615\u2013622","journal-title":"Exp Toxicol Pathol"},{"key":"3988_CR13","doi-asserted-by":"publisher","first-page":"316ra193","DOI":"10.1126\/scitranslmed.aac7071","volume":"7","author":"W Ju","year":"2015","unstructured":"Ju W, Nair V, Smith S, Zhu L, Shedden K, Song PXK, Mariani LH, Eichinger FH, Berthier CC, Randolph A, Lai JY, Zhou Y, Hawkins JJ, Bitzer M, Sampson MG, Thier M, Solier C, Duran-Pacheco GC, Duchateau-Nguyen G, Essioux L, Schott B, Formentini I, Magnone MC, Bobadilla M, Cohen CD, Bagnasco SM, Barisoni L, Lv J, Zhang H, Wang HY, Brosius FC, Gadegbeku CA, Kretzler M, ERCB, C-PROBE, NEPTUNE, and PKU-IgAN Consortium (2015) Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker. Sci Transl Med 7:316ra193","journal-title":"Sci Transl Med"},{"key":"3988_CR14","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.kint.2016.01.015","volume":"89","author":"BB Betz","year":"2016","unstructured":"Betz BB, Jenks SJ, Cronshaw AD, Lamont DJ, Cairns C, Manning JR, Goddard J, Webb DJ, Mullins JJ, Hughes J, McLachlan S, Strachan MWJ, Price JF, Conway BR (2016) Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes. Kidney Int 89:1125\u20131135","journal-title":"Kidney Int"},{"key":"3988_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF00266763","volume":"96","author":"EC Salido","year":"1991","unstructured":"Salido EC, Lakshmanan J, Fisher DA, Shapiro LJ, Barajas L (1991) Expression of epidermal growth factor in the rat kidney. Histochemistry 96:65\u201372","journal-title":"Histochemistry"},{"key":"3988_CR16","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1172\/JCI114359","volume":"84","author":"HD Humes","year":"1989","unstructured":"Humes HD, Cieslinski DA, Coimbra TM, Messana JM, Galvao C (1989) Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. J Clin Invest 84:1757\u20131761","journal-title":"J Clin Invest"},{"key":"3988_CR17","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.humpath.2009.08.024","volume":"41","author":"J Jedlicka","year":"2010","unstructured":"Jedlicka J, Soleiman A, Draganovici D, Mandelbaum J, Ziegler U, Regele H, W\u00fcthrich RP, Gross O, Anders HJ, Segerer S (2010) Interstitial inflammation in Alport syndrome. Hum Pathol 41:582\u2013593","journal-title":"Hum Pathol"},{"key":"3988_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1172\/JCI75852","volume":"125","author":"IG Gomez","year":"2015","unstructured":"Gomez IG, MacKenna DA, Johnson BG, Kaimal V, Roach AM, Ren S, Nakagawa N, Xin C, Newitt R, Pandya S, Xia TH, Liu X, Borza DB, Grafals M, Shankland SJ, Himmelfarb J, Portilla D, Liu S, Chau BN, Duffield JS (2015) Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways. J Clin Invest 125:141\u2013156","journal-title":"J Clin Invest"},{"key":"3988_CR19","doi-asserted-by":"publisher","first-page":"e0141231","DOI":"10.1371\/journal.pone.0141231","volume":"10","author":"M Kim","year":"2015","unstructured":"Kim M, Piaia A, Shenoy N, Kagan D, Gapp B, Kueng B, Weber D, Dietrich W, Ksiazek (2015) Progression of Alport kidney disease in Col4a3 knock out mice is independent of sex or macrophage depletion by clodronate treatment. PLoS One 10:e0141231","journal-title":"PLoS One"},{"key":"3988_CR20","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1177\/0300985815624494","volume":"53","author":"SL Benali","year":"2016","unstructured":"Benali SL, Lees GE, Nabity MB, Aric\u00f2 A, Drigo M, Gallo E, Giantin M, Aresu L (2016) X-linked hereditary nephropathy in Navasota dogs: clinical pathology, morphology, and gene expression during disease progression. Vet Pathol 53:803\u2013812","journal-title":"Vet Pathol"},{"key":"3988_CR21","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1046\/j.1523-1755.2003.00779.x","volume":"63","author":"O Gross","year":"2003","unstructured":"Gross O, Beirowski B, Marie-Louise Koepke ML, Kuck J, Reiner M, Addicks K, Smyth N, Schulze-Lohoff E, Weber M (2003) Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome. Kidney Int 63:438\u2013446","journal-title":"Kidney Int"},{"key":"3988_CR22","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.kint.2016.12.022","volume":"91","author":"EH Bae","year":"2017","unstructured":"Bae EH, Fang F, Williams VR, VR KA, Zhou X, Patel VB, Song X, John R, Oudit GY, Pei Y, Scholey JW (2017) Murine recombinant angiotensin-converting enzyme 2 attenuates kidney injury in experimental Alport syndrome. Kidney Int 91:1347\u20131361","journal-title":"Kidney Int"},{"issue":"5","key":"3988_CR23","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s10157-012-0618-2","volume":"16","author":"P Hari","year":"2012","unstructured":"Hari P, Biswas B, Pandey R, Kalaivani M, Kumar R, Bagga A (2012) Updated height- and creatinine-based equation and its validation for estimation of glomerular filtration rate in children from developing countries. Clin Exp Nephrol 16(5):697\u2013705","journal-title":"Clin Exp Nephrol"},{"key":"3988_CR24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1681\/ASN.V114649","volume":"11","author":"JP Jais","year":"2000","unstructured":"Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Verellen C, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schr\u00f6der C, Sanak M, Krejcova S, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC (2000) X-linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males. J Am Soc Nephrol 11:649\u2013657","journal-title":"J Am Soc Nephrol"},{"key":"3988_CR25","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/ki.2013.479","volume":"85","author":"Y Hashimura","year":"2014","unstructured":"Hashimura Y, Nozu K, Kaito H, Nakanishi K, Fu XJ, Ohtsubo H, Hashimoto F, Oka M, Ninchoji T, Ishimori S, Morisada N, Matsunoshita N, Kamiyoshi N, Yoshikawa N, Iijima K (2014) Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV \u03b15 chain. Kidney Int 85:1208\u20131213","journal-title":"Kidney Int"},{"key":"3988_CR26","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.2215\/CJN.02190312","volume":"7","author":"J Temme","year":"2012","unstructured":"Temme J, Kramer A, Jager KJ, Lange K, Peters F, M\u00fcller GA, Kramar R, Heaf JG, Finne P, Palsson R, Reis\u00e6ter AV, Hoitsma AJ, Metcalfe W, Postorino M, Zurriaga O, Santos JP, Ravani P, Jarraya F, Verrina E, Dekker FW, Gross O (2012) Outcomes of male patients with Alport syndrome undergoing renal replacement therapy. Clin J Am Soc Nephrol 7:1969\u20131976","journal-title":"Clin J Am Soc Nephrol"},{"key":"3988_CR27","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.2215\/CJN.00650111","volume":"6","author":"JC Lamattina","year":"2011","unstructured":"Lamattina JC, Foley DP, Mezrich JD, Fernandez LA, Vidyasagar V, D\u2019Alessandro AM, Musat AI, Samaniego-Picota MD, Pascual J, Alejandro MD, Leverson GE, Pirsch JD, Djamali A (2011) Chronic kidney disease stage progression in liver transplant recipients. Clin J Am Soc Nephrol 6:1851\u20131857","journal-title":"Clin J Am Soc Nephrol"},{"key":"3988_CR28","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/ndt\/gfm590","volume":"23","author":"A Kukla","year":"2008","unstructured":"Kukla A, Adulla M, Pascual J, Samaniego M, Nanovic L, Becker BN, Djamali A (2008) CKD stage-to-stage progression in native and transplant kidney disease. Nephrol Dial Transplant 23:693\u2013700","journal-title":"Nephrol Dial Transplant"},{"key":"3988_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.5414\/CNP75141","volume":"75","author":"CC Lee","year":"2011","unstructured":"Lee CC, Sun CY, Wu IW, Wang SY, Wu MS (2011) Metabolic syndrome loses its predictive power in late-stage chronic kidney disease progression\u2014a paradoxical phenomenon. Clin Nephrol 75:141\u2013149","journal-title":"Clin Nephrol"},{"key":"3988_CR30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/ndt\/gft393","volume":"29","author":"A Marks","year":"2014","unstructured":"Marks A, Fluck N, Prescott GJ, Robertson LM, Simpson WG, Smith WC, Black C (2014) Definitions of progression in chronic kidney disease\u2014predictors and relationship to renal replacement therapy in a population cohort with a 6-year follow-up. Nephrol Dial Transplant 29:333\u2013341","journal-title":"Nephrol Dial Transplant"},{"key":"3988_CR31","doi-asserted-by":"publisher","first-page":"iv124","DOI":"10.1093\/ndt\/gfu028","volume":"29","author":"O Gross","year":"2014","unstructured":"Gross O, Perin L, Deltas C (2014) Alport syndrome from bench to bedside: the potential of current treatment beyond RAAS blockade and the horizon of future therapies. Nephrol Dial Transplant 29:iv124\u2013iv130","journal-title":"Nephrol Dial Transplant"},{"key":"3988_CR32","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1210\/jcem-61-5-997","volume":"61","author":"AL Mattila","year":"1985","unstructured":"Mattila AL, Perheentupa J, Pesonen K, Viinikka L (1985) Epidermal growth factor in human urine from birth to puberty. J Clin Endocrinol Metab 61:997\u20131000","journal-title":"J Clin Endocrinol Metab"},{"key":"3988_CR33","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/0024-3205(82)90769-X","volume":"31","author":"M Uchihashi","year":"1982","unstructured":"Uchihashi M, Hirata Y, Fujita T, Matsukura S (1982) Age-related decrease of urinary excretion of human epidermal growth factor (hEGF). Life Sci 31:679\u2013683","journal-title":"Life Sci"},{"key":"3988_CR34","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1097\/01.ASN.0000090034.71205.74","volume":"14","author":"JP Jais","year":"2003","unstructured":"Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Dahan K, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schr\u00f6der C, Sanak M, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC (2003) X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a \u201cEuropean Community Alport Syndrome Concerted Action\u201d study. J Am Soc Nephrol 14:2603\u20132610","journal-title":"J Am Soc Nephrol"},{"key":"3988_CR35","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ekir.2017.04.011","volume":"2","author":"T Yamamura","year":"2017","unstructured":"Yamamura T, Nozu K, Fu XJ, Nozu Y, Ye MJ, Shono A, Yamanouchi S, Minamikawa S, Morisada N, Nakanishi K, Shima Y, Yoshikawa N, Ninchoji T, Morioka I, Kaito H, Iijima K (2017) Natural history and genotype-phenotype correlation in female X-linked Alport syndrome. Kidney Int Rep 2:850\u2013855","journal-title":"Kidney Int Rep"},{"key":"3988_CR36","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1093\/ndt\/gfn681","volume":"24","author":"E Marcocci","year":"2009","unstructured":"Marcocci E, Uliana V, Bruttini M, Artuso R, Silengo MC, Zerial M, Bergesio F, Amoroso A, Savoldi S, Pennesi M, Giachino D, Rombol\u00e0 G, Fogazzi GB, Rosatelli C, Martinhago CD, Carmellini M, Mancini R, Di Costanzo G, Longo I, Renieri A, Mari F (2009) Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome. Nephrol Dial Transplant 24:1464\u20131471","journal-title":"Nephrol Dial Transplant"},{"key":"3988_CR37","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1111\/j.1523-1755.2004.00560.x","volume":"65","author":"C Pescucci","year":"2004","unstructured":"Pescucci C, Mari F, Longo I, Vogiatzi P, Caselli R, Scala E, Abaterusso C, Gusmano R, Seri M, Miglietti N, Bresin E, Renieri A (2004) Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene. Kidney Int 65:1598\u20131603","journal-title":"Kidney Int"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-018-3988-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-3988-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-3988-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T11:10:04Z","timestamp":1661425804000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-018-3988-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,11]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["3988"],"URL":"https:\/\/doi.org\/10.1007\/s00467-018-3988-1","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,11]]},"assertion":[{"value":"27 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"V.N., W.J, and M.K. hold a patent PCT\/EP2014\/073413 \u201cBiomarkers and methods for progression prediction for chronic kidney disease\u201d. The other authors declared no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The ethical committee of Peking University First Hospital approved the project and informed consents were obtained from all the subjects and their family members.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}